These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24977322)

  • 1. Respiratory viruses, such as 2009 H1N1 influenza virus, could trigger temporal trends in serotypes causing pneumococcal disease.
    Launes C; García-García JJ; Triviño M; Peris N; Pallarés R; Muñoz-Almagro C
    Clin Microbiol Infect; 2014 Dec; 20(12):O1088-90. PubMed ID: 24977322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults.
    Pedro-Botet ML; Burgos J; Luján M; Gimenez M; Rello J; Planes A; Fontanals D; Casas I; Mateu L; Zuluaga P; Ardanuy C; Sabrià M
    Scand J Infect Dis; 2014 Mar; 46(3):185-92. PubMed ID: 24456230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
    Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
    Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Sricharoenchai S; Chokephaibulkit K
    Hum Vaccin Immunother; 2014; 10(7):1866-73. PubMed ID: 25424794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
    Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
    Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
    Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008).
    Esteva C; Selva L; de Sevilla MF; Garcia-Garcia JJ; Pallares R; Muñoz-Almagro C
    Clin Microbiol Infect; 2011 Sep; 17(9):1441-4. PubMed ID: 21729192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.
    Salleras L; Domínguez A; Ciruela P; Izquierdo C; Navas E; Torner N; Borras E
    Clin Microbiol Infect; 2009 Nov; 15(11):997-1001. PubMed ID: 19689466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
    Guevara M; Barricarte A; Gil-Setas A; García-Irure JJ; Beristain X; Torroba L; Petit A; Polo Vigas ME; Aguinaga A; Castilla J
    Clin Microbiol Infect; 2009 Nov; 15(11):1013-9. PubMed ID: 19673968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.